Literature DB >> 23329851

Prediction of glomerular filtration rate in cancer patients by an equation for Japanese estimated glomerular filtration rate.

Yohei Funakoshi1, Yutaka Fujiwara, Naomi Kiyota, Toru Mukohara, Takanobu Shimada, Masanori Toyoda, Yoshinori Imamura, Naoko Chayahara, Michio Umezu, Naoki Otsuki, Ken-ichi Nibu, Hironobu Minami.   

Abstract

BACKGROUND: Assessment of renal function is important for safe cancer chemotherapy, and eligibility criteria for clinical trials often include creatinine clearance. However, creatinine clearance overestimates glomerular filtration rate, and various new formulae have been proposed to estimate glomerular filtration rate. Because these were developed mostly in patients with chronic kidney disease, we evaluated their validity in cancer patients without kidney disease.
METHODS: Glomerular filtration rate was measured by inulin clearance in 45 Japanese cancer patients, and compared with creatinine clearance measured by 24-h urine collection as well as that estimated by the Cockcroft-Gault formula, Japanese estimated glomerular filtration rate developed in chronic kidney disease patients, the Modification of Diet in Renal Disease study equation and the Chronic Kidney Disease Epidemiology Collaboration equation. The Modification of Diet in Renal Disease study and Chronic Kidney Disease Epidemiology Collaboration equations were adjusted for the Japanese population by multiplying by 0.808 and 0.813, respectively.
RESULTS: The mean inulin clearance was 79.2 ± 18.7 ml/min/1.73 m(2). Bias values to estimate glomerular filtration rate for Japanese estimated glomerular filtration rate, the Cockcroft-Gault formula, creatinine clearance measured by 24-h urine collection, the 0.808 × Modification of Diet in Renal Disease study equation and the 0.813 × Chronic Kidney Disease Epidemiology Collaboration equation were 0.94, 9.75, 29.67, 5.26 and -0.92 ml/min/1.73 m(2), respectively. Precision (root-mean square error) was 14.7, 22.4, 39.8, 16.0 and 14.1 ml/min, respectively. Of the scatter plots of inulin clearance versus each estimation formula, the Japanese estimated glomerular filtration rate correlated most accurately with actual measured inulin clearance.
CONCLUSION: The Japanese estimated glomerular filtration rate and the 0.813 × Chronic Kidney Disease Epidemiology Collaboration equation estimated glomerular filtration rate with lower bias and higher precision than the other formulae. We therefore propose Japanese estimated glomerular filtration rate for the estimation of glomerular filtration rate in Japanese cancer patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329851     DOI: 10.1093/jjco/hys235

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  5 in total

1.  Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1.

Authors:  Kanako Shibata; Yoshinari Yasuda; Ryo Kobayashi; Yuichi Ando; Tomoya Shimokata; Hideki Kamiya; Mutsuharu Hayashi; Shoichi Maruyama; Seiichi Matsuo; Makoto Nakao; Teruo Tsuchiya; Hitomi Teramachi
Journal:  Clin Exp Nephrol       Date:  2015-04-19       Impact factor: 2.801

2.  The impact of kidney function in patients on antithrombotic therapy: a post hoc subgroup analysis focusing on recurrent bleeding events from the AFIRE trial.

Authors:  Kunihiko Matsui; Satoshi Yasuda; Koichi Kaikita; Masaharu Akao; Junya Ako; Tetsuya Matoba; Masato Nakamura; Katsumi Miyauchi; Nobuhisa Hagiwara; Kazuo Kimura; Atsushi Hirayama; Hisao Ogawa
Journal:  BMC Med       Date:  2022-02-25       Impact factor: 8.775

3.  Evaluation of Serological Indicators and Glomerular Filtration Rate Equations in Chinese Cancer Patients.

Authors:  Yingna Tong; Xiaobin Liu; Mingxiu Guan; Meng Wang; Lufang Zhang; Dong Dong; Ruifang Niu; Fei Zhang; Yunli Zhou
Journal:  Med Sci Monit       Date:  2017-06-17

4.  Pharmacokinetic study of the oral fluorouracil antitumor agent S-1 in patients with impaired renal function.

Authors:  Keiko Goto; Yutaka Fujiwara; Takeshi Isobe; Naoko Chayahara; Naomi Kiyota; Toru Mukohara; Yukari Tsubata; Takamasa Hotta; Kenji Tamura; Noboru Yamamoto; Hironobu Minami
Journal:  Cancer Sci       Date:  2019-05-11       Impact factor: 6.716

5.  Validity of new methods to evaluate renal function in cancer patients treated with cisplatin.

Authors:  Yohei Funakoshi; Yutaka Fujiwara; Naomi Kiyota; Toru Mukohara; Takanobu Shimada; Masanori Toyoda; Yoshinori Imamura; Naoko Chayahara; Hideo Tomioka; Michio Umezu; Naoki Otsuki; Ken-ichi Nibu; Hironobu Minami
Journal:  Cancer Chemother Pharmacol       Date:  2016-01-20       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.